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Abstract. Although cancer is a leading cause of death, a little is known about the mechanism of 
its growth and destruction. Mathematical models explaining these mechanisms are crucial to 
predict the behaviour of cancer cells proliferation. Perusal of the literature dealing with 
mathematical modelling of cancer initiation, proliferation and metastases is abundant. 
Mathematical models to simulate the growth rate of the cancer cells have been derived from 
both deterministic and stochastic considerations. Early model of tumor growth by diffusion was 
first introduced and then set the scene for many later mathematical models for solid tumors. In 
this article we review the deterministic and stochastic models that have been developing to 
discuss the tumor growth initiation and proliferation. The findings and interpretations are 
summarized, and the main research issues are highlighted. 
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1. Introduction 
  Cancer is one of the world’s deadliest diseases, second leading cause of death in the world. 
Approximately 9.6 million deaths, about 1 in 6 deaths is because of cancer in 2018 by World Health 
Organization report [1]. Putting lot of stress on the financial and health care system because of its 
chronic nature and expensive treatment, also side effects caused by the treatment  [2][3]. Number of 
researchers putting their time and efforts to find an effective treatment and to improve the efficiency of 
current treatment with low cost[4][5].  Cancer is typically initiated by genetic mutations that lead to 
enhance the abnormal of proliferation rate and cell growth. After a certain size, cancer cell stops 
growing and start spreading to the other parts of body, this process is called metastases. 
 Number of mathematical models has been developed to understand the dynamical process of 
cancer cell proliferation. Mathematical models help to predict the stage of tumour and optimize the 
treatment procedure [6].  In deterministic form, there are seven models (Exponential, Mendelsohn, 
logistic, linear, surface, Gompertz, Bartalanffy) have been used to describe the behaviour of cancer cell 
proliferation [7][8][9].  Cancer cell proliferation is subjected to the uncontrolled factors or 
environmental noise which includes cellular metabolism, energy requirements, hormonal oscillations, 
respiration, and individual characteristics such as body mass index, genes, smoking and stress impact 
[10]. Deterministic models are inadequate to explain the dynamical process of the cancer cell 
proliferation. In such a case, research has been done to extend the deterministic model (logistic and 
Gompertz) to their stochastic counterpart [11]. 
This paper reviews the deterministic and stochastic models of cancer growth process. The 
review of the cancer growth process in the form of deterministic part is presented in Section 1. Section 
2 considers the review of stochastic model counterpart. In section 4, the comparisons of both models 
are presented, and conclusion remarks are stated in Section 5.    
 
2. Deterministic Model  
Deterministic model in the form of exponential, logistic, Gomperzt and Bertalanffy have been 
widely used to model the cancer cell growth. This section reviews these four different models. They are 
designed to predict the rate of change in the volume of the tumour with respect to the changes in time, 
t. Logistic, Gompertz and Bertalanffy models share a common pattern of exponential model [9], thus 
this section starts by discussing the exponential model of tumour growth. 
 
 
2.1. Exponential Model 
 Exponential model is the natural description of early stages of cancer growth [12].  In 
exponential model, each cancer cell split into two daughter cells in the affected area at the rate of 
constant, 𝑎. The exponential model is given by 
                                      𝑑𝑣(𝑡) = 𝑎𝑣(𝑡)    
where  𝑎  is the kinetic parameter and 𝑣(𝑡) is the volume of the cancer cells. 
The cancer cell growth in exponential model is proportional to the population of the cancer [13][14]. 
Exponential model estimates the maximum tumour growth volume at doubling time. However, at the 
last stages, the exponential model fails to predict the angiogenesis process and reduction of the nutrient 
[13]. 
2.2. Logistic Model 
The exponential model has limitations to predict the last stages of cancer growth and cannot 
describe the log-term growth rate. To overcome these problems, the logistic model was introduced for 
the improvement [11]. A general equation for the logistic model was first introduced by Pierre Francois 
Verhulst in 1883 to find out the elements of organic population, concentrating on the inherent 
development rate 𝑎, whose entire size is limited by carrying capacity of b. The logistic model equation 
describes that the growth proportional linearly with size unless the carrying capacity become zero, 
which produces S-shape curve for the volume of cancer cell [15], where 𝑎 is the coefficient of 
proliferation kinetics. This model can interpret the mutual competition between the cells and it has been 
used to model cancer tumour in [16]. The generalized logistic model equation is  
                                            𝑑𝑣(𝑡) = 𝑎𝑣(𝑡) (1 −
𝑣(𝑡)
𝑏
)                                                (1) 
  This model has been effectively utilized in different biological phenomena, which ranges from 
bacterial population and portrays tumour development [17][18].  
2.3. Gompertz Model 
 This model is generalization of logistic model with an asymmetric curve with the point of 
inflection. This model has ability to draw the latent stages of cancer tumour. The curve was applied 
ultimately to model growth in the size for whole organisms and the best curve for the growth of breast 
and lung cancer was noticed [27]. This model was first developed by Gompertz in 1825 to explain the 
human mortality curve, which further was employed by many researchers to fit and describe the tumour 
growth data [19]. The mathematical equation for the model is 






)                                                               (2) 
This model is popular for modelling the tumour growth [13][14] as it slows down the process 
of tumour growth as the size of tumour increases. Tjørve et al. [18]  has used mathematical model in 
thriving experimental trials[20]. This model worked good for both clinical and experimental data for 
breast and lung cancer[19]. Ultimately the curve was used to model the growth of whole organisms 
[21].  The Gompertz model and logistic model estimate the maximum tumour volume. 
2.4. Bertalantfy Model 
 This model was introduced as organism growth model by Von Bertalantfy in 1838. This model 
shows that the volume of tumour decreases with cell death and increases related to the surface area. 
According to [16] this model predicts adequate human tumour growth. The equation of this model is as 
                                    
𝑑𝑣
𝑑𝑡
= 𝑎𝑣(𝑡)2/3 − 𝑏𝑣(𝑡) 
For the early tumour growth experimental data this model give the best results, but this model would 
not be good to predict the progression of cancer growth was stated by [22]. 
All the aforementioned models have limitation to predict the last phases of cancer growth and 
cannot predict long-term tumour growth rate. However, amongst of them, Gompertz model has been 
shown to fit and explain the growth of the breast and lung cancer data adequately. The deterministic 
models are not exposed to the uncontrolled factors, thus inadequate to describe the actual behaviour of 
the cancer growth. Section 3 reviews the extension of logistic and Gompertz models to their stochastic 
counterpart. 
3. Stochastic Model 
Cancer is a complex stochastic system. Stochastic model is suitable in providing the analysis 
of tumour growth process and development. It considers the uncontrolled factors of cellular metabolism, 
energy requirements, hormonal oscillations, respiration, and individual characteristics such as body 
mass index, genes, smoking and stress impact [10]. The perturbation of randomness into deterministic 
model has been done few authors on Gompertz model and it is presented in Section 3.1. 
3.1. Stochastic Gompertz Model  
 
              Gompertz deterministic model has been extended to the stochastic Gompertz model by [9] and 
[23]. The numerical results of Gompertz stochastic model are shown to be consistent with the clinical 
data of breast cancer compare than deterministic model. The mathematical equation is formulated by 
perturbing the growth rate parameter a such that equation (2) become 
 
            𝑑𝐴(𝑡) = (𝑎𝑣(𝑡)𝑙𝑛𝑣(𝑡))𝑑𝑡 + 𝜎𝑣(𝑡)𝑑𝑊(𝑡)                                          (3)  
 
where 𝑎  is the intrinsic growth rate, b is the growth rate declaration factor of antiangiogenic process 
and W(t) is a Wiener process with mean zero and variance given by the increment in time, t. Equation 
(3) describe the pattern of breast cancer growth and consistent with the clinical dataThis mathematical 
model provides the good prediction with the low value of MSE (Mean Square Error).  
 
5.  Conclusion 
We have provided here a brief review of the deterministic and stochastic models for cancer cell 
growth. The simplest form of mathematical model in determinsitic setting is exponential model. The 
equation has been extended to the form of logistic, Gompertz and Bertalanffy to describe the volume of 
the cancer cells. It is found that, Gompertz model shows better accuracy than other determinsitic 
models. Gompertz deterministic model has been  extended to stochastic setting by perturbing the growth 
rate parameter, a. Stochastic Gompertz model explain the cervical and breast cancer data adequately as 
shown by [9][26]. 
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